These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 9162011)
1. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Jeltsch M; Kaipainen A; Joukov V; Meng X; Lakso M; Rauvala H; Swartz M; Fukumura D; Jain RK; Alitalo K Science; 1997 May; 276(5317):1423-5. PubMed ID: 9162011 [TBL] [Abstract][Full Text] [Related]
2. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Enholm B; Karpanen T; Jeltsch M; Kubo H; Stenback F; Prevo R; Jackson DG; Yla-Herttuala S; Alitalo K Circ Res; 2001 Mar; 88(6):623-9. PubMed ID: 11282897 [TBL] [Abstract][Full Text] [Related]
3. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889 [TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969 [TBL] [Abstract][Full Text] [Related]
5. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Kukk E; Lymboussaki A; Taira S; Kaipainen A; Jeltsch M; Joukov V; Alitalo K Development; 1996 Dec; 122(12):3829-37. PubMed ID: 9012504 [TBL] [Abstract][Full Text] [Related]
6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204 [TBL] [Abstract][Full Text] [Related]
8. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Partanen TA; Paavonen K Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156 [TBL] [Abstract][Full Text] [Related]
9. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. Saaristo A; Veikkola T; Enholm B; Hytönen M; Arola J; Pajusola K; Turunen P; Jeltsch M; Karkkainen MJ; Kerjaschki D; Bueler H; Ylä-Herttuala S; Alitalo K FASEB J; 2002 Jul; 16(9):1041-9. PubMed ID: 12087065 [TBL] [Abstract][Full Text] [Related]
10. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor C induces angiogenesis in vivo. Cao Y; Linden P; Farnebo J; Cao R; Eriksson A; Kumar V; Qi JH; Claesson-Welsh L; Alitalo K Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14389-94. PubMed ID: 9826710 [TBL] [Abstract][Full Text] [Related]
12. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of VEGF-C and its receptors, VEGFR-2 and VEGFR-3, in endothelial cells of lymphangioma. Implication in autocrine or paracrine regulation of lymphangioma. Huang HY; Ho CC; Huang PH; Hsu SM Lab Invest; 2001 Dec; 81(12):1729-34. PubMed ID: 11742043 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Witzenbichler B; Asahara T; Murohara T; Silver M; Spyridopoulos I; Magner M; Principe N; Kearney M; Hu JS; Isner JM Am J Pathol; 1998 Aug; 153(2):381-94. PubMed ID: 9708799 [TBL] [Abstract][Full Text] [Related]
15. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer. Yonemura Y; Fushida S; Bando E; Kinoshita K; Miwa K; Endo Y; Sugiyama K; Partanen T; Yamamoto H; Sasaki T Eur J Cancer; 2001 May; 37(7):918-23. PubMed ID: 11313181 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia. Lymboussaki A; Olofsson B; Eriksson U; Alitalo K Circ Res; 1999 Nov; 85(11):992-9. PubMed ID: 10571529 [TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Karpanen T; Egeblad M; Karkkainen MJ; Kubo H; Ylä-Herttuala S; Jäättelä M; Alitalo K Cancer Res; 2001 Mar; 61(5):1786-90. PubMed ID: 11280723 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Mäkinen T; Jussila L; Veikkola T; Karpanen T; Kettunen MI; Pulkkanen KJ; Kauppinen R; Jackson DG; Kubo H; Nishikawa S; Ylä-Herttuala S; Alitalo K Nat Med; 2001 Feb; 7(2):199-205. PubMed ID: 11175851 [TBL] [Abstract][Full Text] [Related]
19. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. Baldwin ME; Catimel B; Nice EC; Roufail S; Hall NE; Stenvers KL; Karkkainen MJ; Alitalo K; Stacker SA; Achen MG J Biol Chem; 2001 Jun; 276(22):19166-71. PubMed ID: 11279005 [TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis. Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]